No Data
No Data
The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics
Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics
Guggenheim Maintains Twist Bioscience(TWST.US) With Buy Rating, Cuts Target Price to $50
Express News | Twist Bioscience Corp : Guggenheim Cuts Target Price to $50 From $58
We're Interested To See How Twist Bioscience (NASDAQ:TWST) Uses Its Cash Hoard To Grow
Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last?